CD38 and neoplasm: ,3 The combination of PD-L1 and CD38 blockade led to enhanced antitumor activity, decreased incidence of lung metastasis, and increased tumor infiltration of CD8+ T cells in a murine lung cancer model (K-rasLA1/+ p53R172HΔg/+-derived tumor).